State Street’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.8M Buy
3,227,245
+45,601
+1% +$727K ﹤0.01% 1804
2025
Q4
$51.7M Buy
3,181,644
+102,362
+3% +$1.67M ﹤0.01% 1724
2025
Q3
$46.1M Buy
3,079,282
+52,109
+2% +$635K ﹤0.01% 1767
2025
Q2
$35.3M Buy
3,027,173
+337,630
+13% +$3.07M ﹤0.01% 1866
2025
Q1
$20M Sell
2,689,543
-40,358
-1% -$310K ﹤0.01% 2145
2024
Q4
$16.4M Buy
2,729,901
+178,116
+7% +$982K ﹤0.01% 2330
2024
Q3
$13.1M Buy
2,551,785
+48,885
+2% +$213K ﹤0.01% 2454
2024
Q2
$9.06M Sell
2,502,900
-177,646
-7% -$564K ﹤0.01% 2619
2024
Q1
$8.6M Buy
2,680,546
+88,893
+3% +$344K ﹤0.01% 2670
2023
Q4
$12.7M Buy
2,591,653
+56,612
+2% +$258K ﹤0.01% 2457
2023
Q3
$13.8M Sell
2,535,041
-9,587
-0.4% -$63.4K ﹤0.01% 2405
2023
Q2
$17.1M Sell
2,544,628
-23,414
-0.9% -$174K ﹤0.01% 2340
2023
Q1
$22.7M Buy
2,568,042
+66,589
+3% +$587K ﹤0.01% 2140
2022
Q4
$19.1M Buy
2,501,453
+25,018
+1% +$195K ﹤0.01% 2272
2022
Q3
$17.6M Buy
2,476,435
+137,051
+6% +$1.29M ﹤0.01% 2313
2022
Q2
$18.9M Buy
2,339,384
+464,913
+25% +$4.09M ﹤0.01% 2288
2022
Q1
$26M Buy
1,874,471
+243,581
+15% +$3.83M ﹤0.01% 2208
2021
Q4
$45.8M Buy
1,630,890
+105,132
+7% +$3.22M ﹤0.01% 1867
2021
Q3
$51.9M Buy
1,525,758
+98,837
+7% +$3.57M ﹤0.01% 1778
2021
Q2
$58.3M Buy
1,426,921
+473,378
+50% +$18.4M ﹤0.01% 1731
2021
Q1
$38.4M Sell
953,543
-1,791
-0.2% -$96.9K ﹤0.01% 1935
2020
Q4
$56.5M Buy
955,334
+34,767
+4% +$1.79M ﹤0.01% 1568
2020
Q3
$44.8M Buy
920,567
+107,210
+13% +$4.51M ﹤0.01% 1539
2020
Q2
$39.4M Buy
813,357
+99,461
+14% +$3.63M ﹤0.01% 1596
2020
Q1
$19.8M Buy
713,896
+454,043
+175% +$12.7M ﹤0.01% 1843
2019
Q4
$7.78M Buy
259,853
+112,222
+76% +$3.22M ﹤0.01% 2645
2019
Q3
$4.56M Buy
+147,631
New +$6.03M ﹤0.01% 2829

Other funds holding ADPT